CHF132.00
0.60% yesterday
SIX Swiss Exchange, Aug 12, 05:31 pm CET
ISIN
CH1335392721
Symbol
GALD
Index

Galderma Stock price

CHF132.00
+6.80 5.43% 1M
+18.06 15.85% 6M
+31.36 31.16% YTD
+56.00 73.68% 1Y
+79.00 149.06% 3Y
+79.00 149.06% 5Y
+79.00 149.06% 10Y
+79.00 149.06% 20Y
SIX Swiss Exchange, Closing price Tue, Aug 12 2025
-0.80 0.60%
ISIN
CH1335392721
Symbol
GALD
Index
Industry

Key metrics

Basic
Market capitalization
CHF30.9b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
102.9 | 59.2
P/S
8.1 | 7.5
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
CHF0.15
Yield 1Y | 5Y
0.1% | 0.0%
Growth 1Y | 5Y
100.0% | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
1 Year
Financials (TTM | estimate)
Revenue
CHF3.8b | CHF4.1b
EBITDA
CHF858.1m | CHF925.8m
EBIT
CHF608.9m | CHF796.5m
Net Income
CHF304.8m | -
Free Cash Flow
CHF591.1m
Growth (TTM | estimate)
Revenue
- | 14.9%
EBITDA
- | 17.8%
EBIT
- | 45.3%
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
69.2%
EBITDA
22.7% | 22.3%
EBIT
16.1%
Net
8.1% | -
Free Cash Flow
15.6%
Financial Health
Equity Ratio
61.7%
Return on Equity
3.0%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
CHF1.3
FCF per Share
-
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Galderma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Galderma Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Galderma forecast:

15x Buy
79%
4x Hold
21%

Analyst Opinions

19 Analysts have issued a Galderma forecast:

Buy
79%
Hold
21%

Financial data from Galderma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
3,782 3,782
-
100%
- Direct Costs 1,165 1,165
-
31%
2,618 2,618
-
69%
- Selling and Administrative Expenses 1,631 1,631
-
43%
- Research and Development Expense 185 185
-
5%
858 858
-
23%
- Depreciation and Amortization 249 249
-
7%
EBIT (Operating Income) EBIT 609 609
-
16%
Net Profit 305 305
-
8%

In millions CHF.

Don't miss a Thing! We will send you all news about Galderma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Head office Switzerland
CEO Flemming Ørnskov
Website www.galderma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today